Volastra Therapeutics is developing drugs for cancer metastasis, the cause of the vast majority of cancer deaths. The startup has $44 million in funding and an R&D partnership with Microsoft to develop new digital tools to detect and predict metastasis.
Digital health startups raised a record-breaking $6.7 billion in the first quarter of 2021. Large funding rounds propelled them past previous months.
With the focus on COVID-19 over the last year it’s easy to forget another deadly pandemic caused by antimicrobial resistance (AMR), which could lead to the most innocuous of infections becoming life threatening. The Novo Holding REPAIR Impact Fund is hoping to change this with… Read More »Novo Holding launches latest call for antibiotic investment proposals
Advocate Aurora Health has launched a subsidiary focused on making investments in companies that enhance health and wellbeing. The subsidiary has already made its first move, leading a $25 million funding round for a telenutrition provider.
Ro, a direct-to-consumer health startup, recently raised a $500 million funding round. It plans to use the funds to expand into at-home diagnostics and care.
A new digital health company — spun out from Providence’s Digital Innovation Group — has raised $20 million in its first funding round. The company offers a platform that aims to help providers coordinate and manage digital care services.
The healthcare analytics company will use the funds, raised in a Series C financing round, to scale its cloud-based platform that offers providers, payers and pharma companies insights to inform business decision-making.
Cedar, a healthcare finance technology company, saw its valuation jump to $3.2 billion after raising $200 million in a Series D funding round. It plans to use the new funds to expand patient touchpoints and build out new use cases.
The health technology company’s valuation skyrocketed to $1.3 billion following its latest funding round. It plans to use the new funds to launch Innovaccer Health Cloud, which will aggregate and normalize data from different systems and support the development of interoperable apps.
The company partners with independent practices, health centers and clinics to establish primary care-focused accountable care organizations.
States will get some much needed support to roll out a coronavirus vaccine. Last week, the Department of Health and Human Services shared it would roll out $22 billion in funding to support state testing and vaccination efforts.
DNA testing company 23andMe raised $82.5 million in funding, according to a recent filing. Earlier this year, decreased sales of tests kits led to cuts at the company and its competitors.
With the new funds, the health data optimization and interoperability company will invest in product development. The latest funding round was led by Centene Corp.
The health technology company raised a whopping $130 million in a Series D funding round. Its solutions aim to improve operational efficiency and better manage patient volume through predictive analytics, a growing need for providers as Covid-19 cases rise.
Denmark’s MinervaX has raised €47.4 million (around $56 million) in a Series B funding round to take its novel group B streptococcus (GBS) vaccine into mid-stage clinical trials. When and if the pandemic finally recedes there will still be an ongoing issue with a dearth… Read More »Minervax raises €47.4m in Series B funding round for GBS shot
The technology provider for independent primary care practices plans to use the new funds to further invest in its core platform and add new solutions, such as billing and patient collections capabilities.
SoftBank’s second Vision Fund led the recent funding round. Pear plans to use it to accelerate reimbursement coverage for its three FDA-cleared products.
The Austin-based startup has distributed more than 500,000 Covid-19 test kits to date, and expects total sales to quadruple by the end of the year.
China’s Sinovac has raised $515 million to increase its distribution and production capacity as clinical development of its potential coronavirus vaccine nears conclusion. According to press reports Sino Biopharmaceutical, a Hong Kong-listed generics firm, acquired a 15% stake in a subsidiary of Sinovac. Sinovac has… Read More »Sinovac raises $515m to boost production of potential COVID-19 vaccine
Swiss biotech Noema has raised 54 million Swiss francs ($59m) to develop four neurological disorder drugs licensed in from Roche. The company is developing four phase 2 drugs brought in from Roche after the big Swiss pharma decided somebody else should take the risk of… Read More »Swiss start-up Noema raises $59m to develop neurology drugs offloaded by Roche
Olive AI, a startup automating routine administrative tasks for health systems, raised another $225 million in funding, bringing the total raised this year to $385 million.
The company, a facilitator of patient-clinician communication, plans to use the funds to bring new features and capabilities to market, as well as build strategic partnerships. It has also added Dr. Dana Gelb Safran as senior vice president of value-based care and population health.
A recent report by Rock Health found that Black and female founders of digital health companies received less funding and were more likely to bootstrap their companies than other groups.
Carbon Health, which more than tripled its footprint in the last year, plans to further grow its network of primary care and urgent care clinics with $100 million in new funding.
Lark Health, which offers AI-powered digital care platforms for chronic diseases, has raised $70 million in new funds, which it plans to use to expand its relationship with Anthem and eventually deepen partnerships with other payers and telehealth providers.
Gamified digital therapeutics firm Sidekick Health has raised $20 million in a Series A funding round, which it plans to use to develop its product offering. Based in Iceland, Sidekick said the oversubscribed funding round was led by Wellington Partners and Asabys Partners through its… Read More »Sidekick Health raises $20m to fund digital therapeutics expansion
Honor, a San Francisco-based startup that strikes partnerships with home care companies, raised $140 million in a series D round. The company helps manage back-office functions in exchange for a portion of their revenue.
French biotech SparingVision has raised 44.5 million euros ($52.7 million) to develop its gene therapy for a rare ocular disease. The round was led by 4BIO Capital and UPMC Enterprises with Jeito Capital and Ysios Capital joining. Current investors Bpifrance and Foundation Fighting Blindness also… Read More »SparingVision raises €44.5m for retinitis pigmentosa gene therapy
Carrot Fertility, a startup that provides employee fertility benefits, raised $24 million in a series B round. The company plans to use the funds to further its expansion and build out its telehealth features.
In-home primary care startup Heal raised $100 million in funding, led by Humana. Heal plans to use the funds to expand into new markets and expand the breadth of services that it offers.
Ro, a startup offering patients mail-order prescriptions and telehealth appointments, raised $200 million in funding. The company started three years ago with men’s health and wellness products, before expanding its business.
Insights+ Interview: Paige’s CEO, Leo Grady Shares Insights on its Series B Funding and the FDA’s 510(k) Clearance for FullFocus Viewer
Paige is a global digital pathology founded in 2017 by Thomas Fuchs, Dr. Sc., and colleagues from Memorial Sloan Kettering Cancer Center. The company involves computational pathology products that are targeted for patients and their care teams for effective, more informed treatment decisions. Paige has… Read More »Insights+ Interview: Paige’s CEO, Leo Grady Shares Insights on its Series B Funding and the FDA’s 510(k) Clearance for FullFocus Viewer
Digital health companies once again set a record for funding in 2020, according to a report by Rock Health. They raised a total of $5.4 billion in the first half of the year.